Section of Endocrinology and Metabolism, Medical School, Koç University, Istanbul, Turkey.
Section of Radiology, Amerikan Hospital, Istanbul, Turkey.
Eur Arch Otorhinolaryngol. 2020 May;277(5):1491-1497. doi: 10.1007/s00405-020-05830-1. Epub 2020 Feb 12.
Morbidity due to papillary thyroid carcinoma (PTC) is increased mostly due to lymph node (LN) metastases, which lead to reoperations and complications associated with these operations. The aim is to compare the outcomes of PTC having total thyroidectomy and prophylactic central lymph node dissection (TT + PCND) with patients having total thyroidectomy (TT) alone.
This study is a retrospective cohort analysis of 358 PTC patients that were operated by a single surgeon in a single center. Data about the patients were extracted from the medical records.
Of the patient cohort, 258 patients had TT + PCND (42.5 ± 11.3 years) and 100 patients (41.2 ± 11.9 years) had only TT. Total number of LN extracted in the TT + PCND group was 8.1 ± 6.9. The mean number of metastatic LN were 2.2 ± 1.9. Percentage of patients that had RAI were less in the TT + PCND group compared to the TT group. Seven patients (2.7%) in the TT + PCND group and 19 (19.0%) in TT group had recurrent disease (p < 0.0001). Of the complications, only transient hypoparathyroidism was increased in TT + PCND group compared to TT group (26.7% vs 10%, p < 0.0001).
TT + PCND performed by an experienced surgeon seems to decrease the number of LN recurrences, and the need for reoperations.
甲状腺乳头状癌(PTC)的发病率增加主要是由于淋巴结(LN)转移,这导致了再次手术以及与这些手术相关的并发症。目的是比较行甲状腺全切除术和预防性中央淋巴结清扫术(TT+PCND)与单纯行甲状腺全切除术(TT)的 PTC 患者的结局。
这是一项由单名外科医生在单中心进行的回顾性队列分析,对 358 例 PTC 患者进行了研究。从病历中提取患者的数据。
在患者队列中,258 例患者行 TT+PCND(42.5±11.3 岁),100 例患者仅行 TT(41.2±11.9 岁)。TT+PCND 组中取出的 LN 总数为 8.1±6.9。转移性 LN 的平均数量为 2.2±1.9。与 TT 组相比,接受放射性碘治疗的患者比例在 TT+PCND 组中较低。在 TT+PCND 组中有 7 例(2.7%)患者和 TT 组中有 19 例(19.0%)患者出现疾病复发(p<0.0001)。在并发症中,只有 TT+PCND 组中暂时性甲状旁腺功能减退症的发生率高于 TT 组(26.7%比 10%,p<0.0001)。
由经验丰富的外科医生进行 TT+PCND 似乎可以降低 LN 复发和再次手术的需求。